Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Shares Outstanding (2016 - 2026)

Lexaria Bioscience's Shares Outstanding history spans 12 years, with the latest figure at $24.9 million for Q1 2026.

  • Quarterly results put Shares Outstanding at $24.9 million for Q1 2026, up 41.73% from a year ago — trailing twelve months through Feb 2026 was $24.9 million (up 41.73% YoY), and the annual figure for FY2025 was $19.6 million, changed 0.0%.
  • Shares Outstanding for Q1 2026 was $24.9 million at Lexaria Bioscience, up from $22.2 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $24.9 million in Q1 2026 to a low of $6.0 million in Q1 2022.
  • The 5-year median for Shares Outstanding is $12.4 million (2024), against an average of $13.3 million.
  • The sharpest move saw Shares Outstanding changed 0.0% in 2023, then surged 141.72% in 2024.
  • Year by year, Shares Outstanding stood at $6.0 million in 2022, then surged by 73.28% to $10.3 million in 2023, then surged by 69.25% to $17.5 million in 2024, then grew by 27.35% to $22.2 million in 2025, then rose by 11.98% to $24.9 million in 2026.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $24.9 million, $22.2 million, and $19.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.